SCHEMBL5484397

SCHEMBL5484397

Cc1ccc(C(=O)c2ccccc2)c(C(=O)Cl)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.54
POLB P06746 1/20 0.54
NPSR1 Q6W5P4 1/20 0.52
TP53 P04637 2/20 0.52
GAA P10253 2/20 0.48
MAPT P10636 2/20 0.47
HTT P42858 2/20 0.47
NPC1 O15118 1/20 0.47
MAPK1 P28482 1/20 0.47
PKM P14618 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 1/20 0.46
USP2 O75604 1/20 0.46
KMT2A Q03164 1/20 0.46
KEAP1 Q14145 1/20 0.46
NFE2L2 Q16236 1/20 0.46
CES2 O00748 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28384878 0.89 AKR1C3 (0.61) AKR1C3POLBNPSR1TP53GAA
6-Benzoyl-3-Methylbenzoic Acid SCHEMBL5309754 0.86 AKR1C3 (0.68) AKR1C3POLBNPSR1TP53MAPT
6-Benzoyl-3-Methylbenzoic Acid SCHEMBL5484402 0.84 AKR1C3 (0.66) AKR1C3POLBNPSR1TP53GAA
SCHEMBL4638917 0.83 AKR1C3 (0.54) AKR1C3POLBNPSR1TP53GAA
SCHEMBL9217336 0.82 AKR1C3 (0.68) AKR1C3POLBNPSR1TP53MAPT
SCHEMBL302204 0.81 CSNK2A1 (0.48) POLBMAPTHTTNPC1MAPK1
SCHEMBL10424856 0.81 TDP1 (0.50) GAAMAPTHTTNPC1MAPK1
SCHEMBL257273 0.81 TP53 (0.60) AKR1C3POLBNPSR1TP53GAA
SCHEMBL95646 0.81 TP53 (0.57) AKR1C3POLBNPSR1TP53GAA
SCHEMBL9327289 0.81 AKR1C3 (0.51) AKR1C3POLBNPSR1TP53GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070066837-A1 Podophyllotoxin derivatives as antitumor agents RANBAXY LABORATORIES LIMITED (IN) 2007-03-22 US disclosed
EP-1599485-A2 PODOPHYLLOTOXIN DERIVATIVES AS ANTITUMOR AGENTS RANBAXY LABORATORIES, LTD. (IN) 2005-11-30 EP disclosed
WO-2004073375-A2 PODOPHYLLOTOXIN DERIVATIVES AS ANTITUMOR AGENTS RANBAXY LABORATORIES LIMITED (IN) 2004-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066837-A1 Podophyllotoxin derivatives as antitumor agents DIMT1, CYP51A1, MAGT1 AKR1C3 1820/4885POLB 3725/4885NPSR1 4056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.